EORTC hosting session at ICTR-PHE 2016 in Geneva
9 Dec 2015
The EORTC will host a session at ICTR-PHE 2016, the International Conference on Translational Research in Radio-Oncology – Physics for Health in Europe, from 11:00 – 12:30 on Thursday, 18 February 2016 in Session Room 2 at the Centre International de Conférences Genève in Geneva, Switzerland.
This session will be chaired by Prof Wilfried Budach of Universitaetsklinik in Dusseldorf, Germany. The session will highlight several areas of current EORTC research where the EORTC is making significant contributions towards advancing therapies for patients with cancer.
Speakers include Dr. Damien Weber of the Paul Scherrer Institute Center for Proton Therapy in Villigen, Switzerland, who will present the EORTC radiotherapy quality assurance platform.
Following him, Dr. Sofia Rivera of the Institut Gustave Roussy in Villejuif, France, will discuss Synergy of targeted agents and radiotherapy.
Dr. Rivera will be followed by Dr. Monika Hegi of the Centre Hospitalier Universitaire Vaudois in Lausanne, Switzerland, who will talk about Lessons from translational research in EORTC Glioma trials.
Dr. Conny Vrieling of the Clinique des Grangettes in Chêne-Bougeries, Switzerland, will close the EORTC session with a talk concerning Data from the EORTC Cancer Survivorship Task Force.
Related News
EORTC Quality of Life Group unveils flexible, future-focused strategy for patient-reported outcome assessment in cancer care
22 Apr 2025
EMA-EORTC workshop underscores critical role of patient-reported outcomes and quality of life data in regulatory decision-making
15 Apr 2025
New study confirms link between cancer patients’ quality of life and survival
1 Apr 2025
New Treatment for Recurrent Meningioma: LUMEN-1 Clinical Trial
17 Mar 2025
SISAQOL-IMI Consortium Launches Final Recommendations
6 Feb 2025
World Cancer Day 2025: EORTC’s commitment to older patients
4 Feb 2025
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
11 Dec 2024
Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research
21 Nov 2024
IMMUcan has completed patient enrolment
12 Nov 2024
EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients
5 Nov 2024